KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Gilead Sciences (GILD) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $9.0 million.

  • Gilead Sciences' Long-Term Debt Repayments fell 9196.43% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year decrease of 896.59%. This contributed to the annual value of $2.0 billion for FY2024, which is 1244.44% down from last year.
  • As of Q3 2025, Gilead Sciences' Long-Term Debt Repayments stood at $9.0 million, which was down 9196.43% from $9.0 million recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Long-Term Debt Repayments peaked at $2.5 billion during Q3 2021, and registered a low of $7.0 million during Q4 2024.
  • Over the past 5 years, Gilead Sciences' median Long-Term Debt Repayments value was $1.0 billion (recorded in 2021), while the average stood at $1.0 billion.
  • In the last 5 years, Gilead Sciences' Long-Term Debt Repayments surged by 15000.0% in 2021 and then crashed by 9951.38% in 2025.
  • Quarter analysis of 5 years shows Gilead Sciences' Long-Term Debt Repayments stood at $1.0 billion in 2021, then changed by 0.0% to $1.0 billion in 2022, then surged by 125.0% to $2.2 billion in 2023, then plummeted by 99.69% to $7.0 million in 2024, then grew by 28.57% to $9.0 million in 2025.
  • Its Long-Term Debt Repayments stands at $9.0 million for Q3 2025, versus $9.0 million for Q2 2025 and $1.8 billion for Q1 2025.